Technology Press Releases: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Technology Press Releases.

Press releases published on June 7, 2026

Jun. 7, 2026

GNI Group to Acquire Ayumi Pharmaceutical Holdings, Expanding Its Position as a Global Biopharmaceutical Company

Indeterminate GlobeNewswire

Jun. 7, 2026

Odysight.ai® Establishes At-The-Market (ATM) Program of up to $20 Million to Enhance Financial Flexibility

Indeterminate GlobeNewswire

Jun. 7, 2026

Entrata Collaborates with OpenAI to Define the Future of Autonomous Property Management

Indeterminate GlobeNewswire

Jun. 7, 2026

SK Telecom and NVIDIA Build AI Infrastructure to Power Korea’s AI Innovation

Indeterminate GlobeNewswire

Jun. 7, 2026

NAVER Expands AI Infrastructure With NVIDIA to Serve Surging Global AI Demand

Indeterminate GlobeNewswire

Jun. 7, 2026

NVIDIA and SK hynix Announce Multiyear Technology Partnership to Advance Memory for AI Factories

Indeterminate GlobeNewswire

Jun. 7, 2026

Kindkart appoints new CIO

Indeterminate EIN Presswire

Jun. 7, 2026

Control4 Service Changes Guide Upgrade Planning

Indeterminate EIN Presswire

Jun. 7, 2026

CV5 Capital Supports Growing Number of Managers Launching in Leading Cayman Fund Domicile

Indeterminate EIN Presswire

Jun. 7, 2026

T al Cubo y Tabuga llevan a la televisión dominicana un ciclo formativo sobre IA en la educación

Indeterminate EIN Presswire

Jun. 7, 2026

Diasome Presents Phase 2b Data Demonstrating HDV™-Insulin Lispro Maintains Glycemic Control While Reducing Hypoglycemia in Adults with Type 1 Diabetes

Indeterminate GlobeNewswire

Jun. 7, 2026

GoHealth, Inc. to strengthen its position ahead of AEP 2026 through Restructuring Process supported by key stakeholders

Indeterminate GlobeNewswire

Jun. 7, 2026

Photo Scanning Services 2026 - iMemories Launched Photo Scanning Services for Families Across the USA

Indeterminate GlobeNewswire

Jun. 7, 2026

Boehringer Ingelheim’s survodutide Phase III trial showed targeted 34% visceral and 63% liver fat reduction, while minimizing lean mass loss in pre-specified analysis, supporting improved metabolic health in people living with obesity

Indeterminate GlobeNewswire

Jun. 7, 2026

Zealand Pharma announces Boehringer Ingelheim's survodutide Phase III trial in people living with obesity showed targeted 34% visceral and 63% liver fat reduction, while minimizing lean mass loss in pre-specified analysis

Indeterminate GlobeNewswire

Jun. 7, 2026

Antag Therapeutics presents positive Phase 1 results at the 2026 Scientific Sessions of the American Diabetes Association for AT7687, a first-in-class GIPR antagonist

Indeterminate GlobeNewswire

Jun. 7, 2026

Tabuga and Chile's National Center for Artificial Intelligence bring an educational AI series to Dominican television

Indeterminate EIN Presswire

Jun. 7, 2026

Astrall Dynamics Unveils Integrated Quadruped Firefighting Robot Hypertron-T01 at INTERSCHUTZ 2026

Indeterminate GlobeNewswire

Jun. 7, 2026

Astrall Dynamics presenterer den integrerte firbente brannslokkingsroboten Hypertron-T01 ved INTERSCHUTZ 2026

Indeterminate GlobeNewswire

Jun. 7, 2026

Crypto News Today: AlphaPepe Presale Hits 9300 Holders While Bitcoin Price Prediction Targets $50,000

Indeterminate GlobeNewswire